Abstract Coronavirus disease 2019 (COVID-19) has emerged as a serious threat to global
health. The disregulation of the phosphatidylinositol 3-kinase/protein kinase B/mammalian …

Abstract Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). A single-stranded RNA virus from a β …

Some COVID-19 patients suffer complications from anti-viral immune responses which can
lead to both a dangerous cytokine storm and development of blood-borne factors that render …

Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection has led to more than 150 million infections …

To the editor Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), poses a major challenge to the world's healthcare …

In December 2019, a novel coronavirus infection appeared in China (Wuhan City and Hubei
Province), causing the first cases of abnormal severe pneumonia. Since then, the SARS …

How severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections engage
cellular host pathways and innate immunity in infected cells remains largely elusive. We …

The SARS-CoV-2 infection triggers host kinases and is responsible for heavy
phosphorylation in the host and also in the virus. Notably, phosphorylations in virus were …

The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed …

The novel betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
emerged at the end of 2019 and caused the coronavirus disease 19 (COVID‐19) pandemic …